• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于跨学科整合肿瘤学小组的方案:对癌症患者韧性和补充与替代医学使用的长期效果评估。

Interdisciplinary Integrative Oncology Group-Based Program: Evaluation of Long-Term Effects on Resilience and Use of Complementary and Alternative Medicine in Patients With Cancer.

机构信息

Department of Radiotherapy, Hannover Medical School, Hannover, Germany.

CCC Hannover (Claudia von Schilling Center), Klaus Bahlsen Center for Integrative Oncology, Hannover Medical School, Hannover, Germany.

出版信息

Integr Cancer Ther. 2024 Jan-Dec;23:15347354241269931. doi: 10.1177/15347354241269931.

DOI:10.1177/15347354241269931
PMID:39155547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11331462/
Abstract

BACKGROUND

Cancer often causes reduced resilience, quality of life (QoL) and poorer overall well-being. To mitigate these problems, complementary and alternative medicine (CAM) is widely used among patients with cancer. This study aimed to evaluate the long-term effects of an interdisciplinary integrative oncology group-based program (IO-GP) on the resilience and use of CAM in patients with cancer.

METHODS

This was a prospective, observational, single-center study. Resilience (RS-13), CAM usage (I-CAM-G), QoL (SF-12) and health-related lifestyle factor (nutrition, smoking, alcohol consumption and physical exercise) data were collected for 70 patients who participated in a 10-week IO-GP between January 2019 and June 2022 due to cancer. The IO-GP is offered at the setting of a university hospital and is open to adult patients with cancer. It contains elements from mind-body medicine and positive psychology, as well as recommendations on healthy diet, exercise and CAM approaches. Patients who completed the IO-GP at least 12 months prior (1-4.5 years ago) were included in this study. Statistical analysis included descriptive analysis and parametric and nonparametric tests to identify significant differences ( < .05).

RESULTS

Resilience increased significantly ≥12 months after participation in the IO-GP (n = 44,  = .006,  = 8.274) and had a medium effect size ( = .410). The time since the IO-GP was completed ("12-24 months," "24-36 months," and ">36 months") showed no statistically significant interaction with changes in resilience ( = .226,  = 1.544). The most frequently used CAM modalities within the past 12 months were vitamins/minerals (85.7%), relaxation techniques (54.3%), herbs and plant medicine (41.1%), yoga (41.4%) and meditation (41.4%). The IO-GP was the most common source informing study participants about relaxation techniques (n = 24, 64.9%), meditation (n = 21, 72.4%) and taking vitamin D (n = 16, 40.0%). Significantly greater levels of resilience were found in those practicing meditation ( = .010,  = -.642) or visualization ( = .003,  = -.805) compared to non-practitioners.

CONCLUSION

IO-GPs have the potential to empower patients with cancer to continue using CAM practices-especially from mind-body medicine-even 1 to 4.5 years after completing the program. Additionally, resilience levels increased. These findings provide notable insight into the long-term effects of integrative oncology interventions on resilience and the use of CAM, especially in patients with breast cancer.

摘要

背景

癌症常导致患者的适应力下降、生活质量(QoL)下降和整体健康状况恶化。为了缓解这些问题,癌症患者广泛使用补充和替代医学(CAM)。本研究旨在评估基于跨学科整合肿瘤学小组的方案(IO-GP)对癌症患者适应力和 CAM 使用的长期影响。

方法

这是一项前瞻性、观察性、单中心研究。70 名癌症患者参与了 10 周的 IO-GP,研究收集了他们的适应力(RS-13)、CAM 使用(I-CAM-G)、生活质量(SF-12)和健康相关生活方式因素(营养、吸烟、饮酒和体育锻炼)的数据。IO-GP 在大学医院进行,面向癌症成年患者,包含身心医学和积极心理学元素,以及关于健康饮食、运动和 CAM 方法的建议。本研究纳入了至少在 12 个月前(1-4.5 年前)完成 IO-GP 的患者。统计分析包括描述性分析和参数和非参数检验,以确定显著差异( < .05)。

结果

参加 IO-GP 后 12 个月以上,适应力显著增加(n = 44, = .006, = 8.274),且具有中等效应量( = .410)。IO-GP 完成时间(“12-24 个月”、“24-36 个月”和“>36 个月”)与适应力变化之间没有统计学上的显著交互作用( = .226,  = 1.544)。在过去 12 个月内,最常使用的 CAM 方式是维生素/矿物质(85.7%)、放松技术(54.3%)、草药和植物药(41.1%)、瑜伽(41.4%)和冥想(41.4%)。IO-GP 是最常见的信息来源,告知研究参与者放松技术(n = 24,64.9%)、冥想(n = 21,72.4%)和服用维生素 D(n = 16,40.0%)。与非练习者相比,练习冥想( = .010,  = -.642)或可视化( = .003,  = -.805)的患者具有更高的适应力水平。

结论

IO-GP 有可能使癌症患者能够继续使用 CAM 实践,特别是在完成方案 1 至 4.5 年后——这是一种从身心医学获得的力量。此外,适应力水平有所提高。这些发现为综合肿瘤学干预对适应力和 CAM 使用的长期影响提供了重要的见解,特别是在乳腺癌患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7933/11331462/985a2394ac3f/10.1177_15347354241269931-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7933/11331462/2b557ee3f16d/10.1177_15347354241269931-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7933/11331462/985a2394ac3f/10.1177_15347354241269931-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7933/11331462/2b557ee3f16d/10.1177_15347354241269931-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7933/11331462/985a2394ac3f/10.1177_15347354241269931-fig2.jpg

相似文献

1
Interdisciplinary Integrative Oncology Group-Based Program: Evaluation of Long-Term Effects on Resilience and Use of Complementary and Alternative Medicine in Patients With Cancer.基于跨学科整合肿瘤学小组的方案:对癌症患者韧性和补充与替代医学使用的长期效果评估。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241269931. doi: 10.1177/15347354241269931.
2
Effects of an Interdisciplinary Integrative Oncology Group-Based Program to Strengthen Resilience and Improve Quality of Life in Cancer Patients: Results of a Prospective Longitudinal Single-Center Study.基于跨学科整合肿瘤学小组的方案对增强癌症患者韧性和改善生活质量的影响:一项前瞻性纵向单中心研究的结果。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221081770. doi: 10.1177/15347354221081770.
3
Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.综合性肿瘤治疗方案与晚期妇科癌症患者生存的相关性。
Support Care Cancer. 2021 Jul;29(7):4055-4064. doi: 10.1007/s00520-020-05961-5. Epub 2021 Jan 6.
4
The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.参与身心与能量疗法的艾滋病病毒感染者的经历:定性证据的系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):41-9. doi: 10.11124/jbisrir-2015-2321.
5
Being in touch: narrative assessment of patients receiving online integrative oncology treatments during COVID-19.保持联系:对COVID-19期间接受在线综合肿瘤治疗的患者的叙事评估
Support Care Cancer. 2021 Aug;29(8):4819-4825. doi: 10.1007/s00520-021-06026-x. Epub 2021 Feb 4.
6
Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.评价专家指导的综合治疗方案在接受系统治疗的乳腺癌或妇科癌症患者中的应用。
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20949444. doi: 10.1177/2515690X20949444.
7
Association Between Physical Activity and Use of Complementary Medicine by Female Oncology Patients in an Integrative Palliative Care Setting.体力活动与综合姑息治疗环境中女性肿瘤患者补充医学使用之间的关联。
J Altern Complement Med. 2020 Aug;26(8):721-728. doi: 10.1089/acm.2019.0437. Epub 2020 Jul 14.
8
Implementation of Virtual Integrative Oncology Shared Medical Appointment Series (VIOSMAS) Within Mixed Diagnosis Population.混合诊断人群中虚拟综合肿瘤学共病门诊系列(VIO-SMAS)的实施。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354231223969. doi: 10.1177/15347354231223969.
9
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.补充和替代医学的使用与乳腺癌化疗起始的相关性:乳腺癌护理质量(BQUAL)研究。
JAMA Oncol. 2016 Sep 1;2(9):1170-6. doi: 10.1001/jamaoncol.2016.0685.
10
War and Cancer: Exploring Patient Narratives in a Randomized Integrative Oncology Study.战争与癌症:在一项随机综合肿瘤学研究中探索患者的故事
Psychooncology. 2025 May;34(5):e70172. doi: 10.1002/pon.70172.

本文引用的文献

1
Resilience and its related factors among women with breast cancer.乳腺癌患者的韧性及其相关因素。
Eur J Cancer Prev. 2024 Mar 1;33(2):129-135. doi: 10.1097/CEJ.0000000000000839. Epub 2023 Sep 11.
2
Use of CAM among cancer patients : Results of a regional survey in Sweden.癌症患者对补充替代医学的应用:瑞典区域性调查结果。
BMC Complement Med Ther. 2023 Feb 16;23(1):51. doi: 10.1186/s12906-023-03876-2.
3
Prevalence of late and long-term effects of cancer (treatment) and use of complementary and alternative medicine in Norway.
挪威癌症(治疗)晚期和长期影响以及补充和替代医学的使用情况。
BMC Complement Med Ther. 2022 Dec 5;22(1):322. doi: 10.1186/s12906-022-03790-z.
4
Resilience in cancer patients and how it correlates with demographics, psychological factors, and lifestyle.癌症患者的韧性及其与人口统计学、心理因素和生活方式的相关性。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5279-5287. doi: 10.1007/s00432-022-04480-6. Epub 2022 Nov 18.
5
Effects of progressive muscle relaxation on health-related outcomes in cancer patients: A systematic review and meta-analysis of randomized controlled trials.渐进性肌肉松弛对癌症患者健康相关结局的影响:系统评价和随机对照试验的荟萃分析。
Complement Ther Clin Pract. 2022 Nov;49:101676. doi: 10.1016/j.ctcp.2022.101676. Epub 2022 Oct 31.
6
Safety and use of complementary and alternative medicine in Norway during the first wave of the COVID-19 pandemic using an adapted version of the I-CAM-Q; a cross-sectional survey.在 COVID-19 大流行第一波期间,挪威使用经过改编的 I-CAM-Q 版本进行的补充和替代医学的安全性和使用情况;一项横断面调查。
BMC Complement Med Ther. 2022 Sep 3;22(1):234. doi: 10.1186/s12906-022-03656-4.
7
Combined lifestyle, mental health, and mortality in US cancer survivors: a national cohort study.美国癌症幸存者的综合生活方式、心理健康和死亡率:一项全国队列研究。
J Transl Med. 2022 Aug 19;20(1):376. doi: 10.1186/s12967-022-03584-4.
8
Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway.在癌症背景下使用补充和替代医学;挪威癌症患者的流行率、使用原因、披露、获得的信息、报告的风险和益处。
BMC Complement Med Ther. 2022 Jul 29;22(1):202. doi: 10.1186/s12906-022-03606-0.
9
Operational definition of complementary, alternative, and integrative medicine derived from a systematic search.从系统搜索中得出的补充、替代和整合医学的操作性定义。
BMC Complement Med Ther. 2022 Apr 12;22(1):104. doi: 10.1186/s12906-022-03556-7.
10
Effects of an Interdisciplinary Integrative Oncology Group-Based Program to Strengthen Resilience and Improve Quality of Life in Cancer Patients: Results of a Prospective Longitudinal Single-Center Study.基于跨学科整合肿瘤学小组的方案对增强癌症患者韧性和改善生活质量的影响:一项前瞻性纵向单中心研究的结果。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221081770. doi: 10.1177/15347354221081770.